Editor’s Pick

In this in-depth walkthrough, Grayson introduces the brand-new Market Summary Dashboard, an all-in-one resource designed to help you analyze the market with ease, speed, and depth. Follow along as Grayson…

Michael F. Cannon I’m usually the guy reminding everybody, “It is not a ‘price control’ when the government reduces the prices [it] pays for drugs.” I expected that I would…

Earnings season continues, and this week we’re looking at three companies heading into their reports with different trajectories. One is in a long-term downtrend, one has been a steady riser,…

Sector Shuffle: Same Players, New Positions The past week brought an unusual shake-up in the RRG sector ranking model. While the composition of the top five sectors, and thus the…

Michael F. Cannon Government should not purchase medicines for civilians. Period. The US Medicare and Medicaid programs illustrate why. Medicare pays significantly higher prices for medicines than other government programs.…

Walter Olson I had missed the story from two weeks ago about what happened after (apparent) agents of the US Immigration and Customs Enforcement (ICE), one wearing a balaclava to…

Amid ever-increasing uncertainties on the global front and similarly rising geopolitical tensions between India and Pakistan, the Indian equity markets demonstrated strong resilience. They consolidated before ending the week on…

Is a recession coming? In this video, Julius breaks down the latest updates to his powerful Sector Rotation Model, analyzing four key macroeconomic indicators and their impact on sector performance.…

Want to know where the stock market is headed next? In this week’s market update, Mary Ellen McGonagle analyzes key resistance levels and reveals what’s fueling the current uptrend. She…

When your investment portfolio isn’t gaining ground, it’s natural to feel uneasy, especially in a market that lacks direction. A headline-driven environment only adds to the uneasiness, making it more…